← Back to catalogue
ENQUIRE ABOUT THIS RESEARCH COMPOUND →
Performance & Recovery
Ipamorelin
10mg
Ipamorelin is a selective growth-hormone secretagogue studied in research involving ghrelin-receptor signalling and pulsatile GH release.
Research focusGrowth-hormone secretagogue research
PresentationLyophilised peptide · 10mg · 3 mL vial
Research overview
Ipamorelin is a peptide growth-hormone secretagogue that acts through the ghrelin receptor (GHSR). Research has focused on GH release and the selectivity of its secretagogue activity relative to older compounds in the same class.
Evidence status
Early human and preclinical research
Ipamorelin has experimental and early human pharmacology literature, but it does not have the breadth of clinical evidence associated with established therapeutic peptides.
Research use only. Not for human consumption. This page is educational and does not provide medical advice or dosing guidance.
Areas under investigation
- Ghrelin-receptor (GHSR) signalling
- Growth-hormone secretagogue activity
- Endocrine selectivity research
Explore the scientific literature
For primary-source reading, search the indexed biomedical literature and registered clinical studies. These links are provided as research gateways rather than endorsements of any particular finding.
PUBLISHED STUDY MAP
See a source-linked study design for Ipamorelin: population, route, timeframe and endpoint — without dosing recommendations.
OPEN STUDY MAP →